Marketing Ethics
Marketing ethics is a neighborhood of applied ethics which deals with the moral principles behind the operation and regulation of selling . Some areas of selling ethics (ethics of
advertising and promotion) overlap with
media and PR ethics. Contrary to popular impressions, not all
marketing is adversarial, and not all
marketing is stacked in favour of the marketer. In marketing, the connection between producer/consumer or buyer/seller are often adversarial or cooperative. For an example of cooperative marketing, see relationship marketing. If the
marketing situation is adversarial, another dimension of difference emerges, describing the facility balance between producer/consumer or buyer/seller. Power could also be concentrated with the producer (caveat emptor), but factors like over-supply or legislation can shift the facility towards the buyer (caveat vendor). Identifying where the facility within the relationship lies and whether the facility balance has relevancy in the least are important to understanding the background to an ethical dilemma in
marketing ethics. A popularist anti-marketing stance commonly discussed on the blogosphere and popular literature is that any quite
marketing is inherently evil. The position is predicated on the argument that
marketing necessarily commits a minimum of one among three wrongs: Damaging personal autonomy. The victim of selling during this case is that the intended buyer whose right to self-determination is infringed. Causing harm to competitors. Excessively fierce competition and unethical
marketing tactics are especially related to saturated markets. Manipulating social values. The victim during this case is society as an entire , or the
environment also . The argument is that
marketing promotes consumerism and waste. See also: affluenza, ethical consumerism, anti-consumerism.
High Impact List of Articles
-
Corrigendum: Clinical Investigation (2015) Vol 5, Iss 12.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 5, Iss 12.
Corrigendum: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Attention must be paid: adverse event reporting needs improvement
Samuel J Kessler and Charles L Bennett
Editorial: Clinical Investigation
-
Attention must be paid: adverse event reporting needs improvement
Samuel J Kessler and Charles L Bennett
Editorial: Clinical Investigation
-
Beyond Jadad: some essential features in trial quality
Sunny Y Alperson ,Vance W Berger
Perspective: Clinical Investigation
-
Beyond Jadad: some essential features in trial quality
Sunny Y Alperson ,Vance W Berger
Perspective: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
-
New strategies for the treatment of inflammatory bowel diseases
Xavier Roblin, William Dronne, Stephane Paul, Emilie Del Tedesco
Review: Clinical Trail Outcomes: Clinical Investigation
Relevant Topics in Clinical